Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.

Kasaian K, Chindris AM, Wiseman SM, Mungall KL, Zeng T, Tse K, Schein JE, Rivera M, Necela BM, Kachergus JM, Casler JD, Mungall AJ, Moore RA, Marra MA, Copland JA, Thompson EA, Smallridge RC, Jones SJ.

J Clin Endocrinol Metab. 2015 Apr;100(4):E611-5. doi: 10.1210/jc.2014-3622. Epub 2015 Jan 27.

2.
3.

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.

Ganly I, Ricarte Filho J, Eng S, Ghossein R, Morris LG, Liang Y, Socci N, Kannan K, Mo Q, Fagin JA, Chan TA.

J Clin Endocrinol Metab. 2013 May;98(5):E962-72. doi: 10.1210/jc.2012-3539. Epub 2013 Mar 29.

4.

The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Chiappetta G, Toti P, Cetta F, Giuliano A, Pentimalli F, Amendola I, Lazzi S, Monaco M, Mazzuchelli L, Tosi P, Santoro M, Fusco A.

J Clin Endocrinol Metab. 2002 Jan;87(1):364-9.

PMID:
11788677
5.

Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.

Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC.

Lab Invest. 1999 May;79(5):547-55.

PMID:
10334566
6.

RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?

Musholt PB, Imkamp F, von Wasielewski R, Schmid KW, Musholt TJ.

Surgery. 2003 Dec;134(6):881-9; discussion 889.

PMID:
14668719
7.

Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.

Nord B, Larsson C, Wong FK, Wallin G, Teh BT, Zedenius J.

Genes Chromosomes Cancer. 1999 Sep;26(1):35-9.

PMID:
10441003
8.

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.

Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M.

Br J Cancer. 2005 May 23;92(10):1892-8.

9.

Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization.

Erickson LA, Jalal SM, Goellner JR, Law ME, Harwood A, Jin L, Roche PC, Lloyd RV.

Am J Surg Pathol. 2001 Jul;25(7):911-7.

PMID:
11420462
10.

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.

Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL.

Am J Surg Pathol. 2003 Dec;27(12):1559-64.

PMID:
14657716
12.

Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.

Sobrinho-Simões M, Máximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC.

Int J Surg Pathol. 2005 Jan;13(1):29-35. Review.

PMID:
15735852
13.

[Multiple endocrine neoplasia: genetic aspects].

Calender A; Groupe d'étude des Tumeurs Endocrines.

Bull Acad Natl Med. 2010 Jan;194(1):81-95; discussion 95-6. Review. French.

PMID:
20669561
14.

Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.

Máximo V, Preto A, Crespo A, Rocha AS, Machado JC, Soares P, Sobrinho-Simões M.

BMC Cancer. 2004 Mar 25;4:12.

15.

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.

Cancer. 2003 Mar 1;97(5):1186-94.

16.

A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E.

BMC Cancer. 2015 Mar 21;15:157. doi: 10.1186/s12885-015-1122-3.

17.

Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.

Yang GC, Schreiner AM, Sun W.

Cytopathology. 2013 Jun;24(3):185-93. doi: 10.1111/j.1365-2303.2012.00988.x. Epub 2012 Jun 6.

PMID:
22672530
18.

PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.

Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW.

Endocr Pathol. 2015 Dec;26(4):365-9. doi: 10.1007/s12022-015-9403-6.

PMID:
26530486
19.

Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.

Hoos A, Stojadinovic A, Singh B, Dudas ME, Leung DH, Shaha AR, Shah JP, Brennan MF, Cordon-Cardo C, Ghossein R.

Am J Pathol. 2002 Jan;160(1):175-83.

20.

Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.

Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK, Kay GF.

Int J Cancer. 2007 Jan 15;120(2):259-67.

Supplemental Content

Support Center